WAKE FOREST UNIVERSITY HEALTH SCIENCES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Histamine and Bone Pain Association in Participants With Breast Cancer Metastatic in the Bone

Active, not recruiting

Conditions: Breast Carcinoma Metastatic in the Bone
Bone Pain

Interventions: Procedure: Biospecimen Collection
Other: Laboratory Biomarker Analysis
Other: Quality-of-Life Assessment
Other: Questionnaire Administration

First Posted Date: 2018-05-18

Last Posted Date: 2024-07-10

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 17

Registration Number: NCT03529565

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Habitual Diet and Avocado Trial

Not Applicable

Completed

Conditions: Intra-abdominal Fat
Liver Fat
HDL Cholesterol, Low Serum
Cardiovascular Risk Factor
Diabetes
Metabolic Syndrome
High Cholesterol
Diet Habit
Cardiovascular Diseases
High Blood Sugar

Interventions: Other: Intervention Daily Avocado

First Posted Date: 2018-05-17

Last Posted Date: 2023-03-22

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 1008

Registration Number: NCT03528031

Locations: 🇺🇸
Tufts University, Boston, Massachusetts, United States
🇺🇸
Loma Linda University, Loma Linda, California, United States
🇺🇸
University of California Los Angles (UCLA), Los Angeles, California, United States

and more 1 locations

Anxiety and Depression in Epilepsy: A Pilot Treatment Study

Phase 4

Withdrawn

Conditions: Depression
Anxiety
Epilepsy

Interventions: Drug: Escitalopram 10mg

First Posted Date: 2018-05-14

Last Posted Date: 2019-09-12

Lead Sponsor: Wake Forest University Health Sciences

Registration Number: NCT03522987

Locations: 🇺🇸
Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States

RAVE: Radial Artery Vascular Complication and Resource Utilization

Not Applicable

Completed

Conditions: Percutaneous Coronary Intervention
Angiogram

Interventions: Device: TR BAND® Compression device plus ®-STF hemostatic pad
Device: VascBand™ Hemostat
Device: RadAR EasyCLik plus ®-STF hemostatic pad
Device: SoftSeal®-STF hemostatic pad

First Posted Date: 2018-05-11

Last Posted Date: 2024-10-03

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 300

Registration Number: NCT03522077

Locations: 🇺🇸
Aurora Health Care, Milwaukee, Wisconsin, United States

Systems Support Mapping in Guiding Self-Management in Stage I-III Colorectal Cancer Survivors

Not Applicable

Completed

Conditions: Cancer Survivor
Stage IIA Colorectal Cancer AJCC v8
Stage IIB Colorectal Cancer AJCC v8
Stage II Colorectal Cancer AJCC v8
Stage III Colorectal Cancer AJCC v8
Stage IIIB Colorectal Cancer AJCC v8
Stage IIIA Colorectal Cancer AJCC v8
Stage IIIC Colorectal Cancer AJCC v8
Stage I Colorectal Cancer AJCC v8
Stage IIC Colorectal Cancer AJCC v8

Interventions: Other: Interview
Other: Questionnaire Administration
Behavioral: System Support Mapping

First Posted Date: 2018-05-09

Last Posted Date: 2021-04-19

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 24

Registration Number: NCT03520283

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Retropubic vs. Single-Incision Mid-Urethral Sling for Stress Urinary Incontinence

Not Applicable

Completed

Conditions: Pelvic Floor Disorders
Stress Urinary Incontinence

Interventions: Device: RP sling placement
Device: SIS placement

First Posted Date: 2018-05-09

Last Posted Date: 2024-10-11

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 280

Registration Number: NCT03520114

Locations: 🇺🇸
Northwell Health, Manhasset, New York, United States
🇺🇸
Women & Infants Hospital of Rhode Island, Providence, Rhode Island, United States
🇺🇸
MedStar Health/National Center for Advance Pelvic Surgery, Washington, District of Columbia, United States

and more 3 locations

HIRREM Hot Flashes Study

Not Applicable

Completed

Conditions: Vasomotor Symptoms
Menopause
Hot Flashes

Interventions: Device: HIRREM
Other: Continued Current Care

First Posted Date: 2018-04-30

Last Posted Date: 2023-05-23

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 8

Registration Number: NCT03512002

Locations: 🇺🇸
Department of Neurology, Wake Forest School of Medicine, Winston-Salem, North Carolina, United States

Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer

Completed

Conditions: Anatomic Stage IB Breast Cancer AJCC v8
Prognostic Stage II Breast Cancer AJCC v8
Prognostic Stage III Breast Cancer AJCC v8
Anatomic Stage III Breast Cancer AJCC v8
Premenopausal
Prognostic Stage IA Breast Cancer AJCC v8
Prognostic Stage IIIB Breast Cancer AJCC v8
Anatomic Stage IIA Breast Cancer AJCC v8
Anatomic Stage IIB Breast Cancer AJCC v8
Anatomic Stage IIIA Breast Cancer AJCC v8

Interventions: Biological: Adenosine
Procedure: Magnetic Resonance Imaging
Drug: Regadenoson
Procedure: Stress Management Therapy

First Posted Date: 2018-04-23

Last Posted Date: 2020-03-26

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 25

Registration Number: NCT03505736

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Acupuncture in Reducing Chemotherapy-Induced Peripheral Neuropathy in Participants With Stage I-III Breast Cancer

Not Applicable

Completed

Conditions: Anatomic Stage IIA Breast Cancer AJCC v8
Grade 2 Peripheral Sensory Neuropathy, CTCAE
Prognostic Stage IB Breast Cancer AJCC v8
Prognostic Stage III Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8
Grade 1 Peripheral Sensory Neuropathy, CTCAE
Prognostic Stage IIB Breast Cancer AJCC v8
Anatomic Stage IIIC Breast Cancer AJCC v8
Grade 1 Peripheral Motor Neuropathy, CTCAE
Grade 2 Peripheral Motor Neuropathy, CTCAE

Interventions: Procedure: Acupuncture Therapy
Other: Best Practice
Other: Quality-of-Life Assessment
Other: Questionnaire Administration

First Posted Date: 2018-04-23

Last Posted Date: 2022-06-01

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 23

Registration Number: NCT03505671

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Tailored Prednisone Reduction in Preventing Hyperglycemia in Participants With B-Cell Non-Hodgkin Lymphoma Receiving Combination Chemotherapy Treatment

Phase 2

Active, not recruiting

Conditions: B-Cell Non-Hodgkin Lymphoma

Interventions: Drug: Cyclophosphamide
Drug: Doxorubicin Hydrochloride
Other: Laboratory Biomarker Analysis
Drug: Prednisone
Other: Quality-of-Life Assessment
Other: Questionnaire Administration
Biological: Rituximab
Drug: Vincristine Sulfate

First Posted Date: 2018-04-23

Last Posted Date: 2025-01-09

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 80

Registration Number: NCT03505762

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy